Bird flu isn’t part of the “quad-demic” of viruses circulating through the country this winter—COVID, seasonal flu, respiratory syncytial virus (RSV), and norovirus—and its risk to public health, according to the Centers for Disease Control and Prevention (CDC),

The US Department of HHS is awarding the pharmaceutical company Moderna $590 million to continue developing a vaccine to protect against bird flu.

The Department of Health and Human Services has granted millions of dollars to Moderna to speed up bird flu vaccine development.

The government wants Moderna to push forward with various bird flu vaccines as well as mRNA shots for other influenza strains with pandemic potential.

Georgia officials halted all in-state poultry sales, and the U.S. Department of Health and Human Services awarded $590 million to Moderna to develop vaccines to protect people from flu strains in bird

When it comes to the growing potential for a bird flu outbreak, the key question is whether the new Trump administration has the political will to prioritize Americans’ health. Trump’s

The Department of Health and Human Services (HHS) will award roughly $590 million to Moderna to accelerate the development of mRNA-based pandemic influenza vaccines, including vaccines for avian flu strains, to ensure the United States is better prepared for future potential pandemics, according to a recent HHS news release.

The government is working to head off human bird flu infections. The U.S. government has awarded Moderna $590 million to advance the development of its bird flu vaccine, as the country doubles down on efforts to tackle increasing infections in humans.

US health officials announced Friday they were awarding $590 million to Moderna to develop mRNA vaccines against influenza, including advancing the company's bird flu vaccine, as fears of a new pandemic grow.

Watch live as RFK Jr. faces questions from senators in his confirmation hearing as President Trump’s nominee to lead the Department of Health and Human Services.

Bird flu was first detected in domestic birds in 1996 in Southern China and has since spread to wild birds, mammals, and humans worldwide, with a fatality rate reaching 50% in some cases. In the U.S., cases have been mostly mild, affecting primarily poultry and dairy workers, until this recent death in Louisiana.

Last Friday, HHS announced it will provide approximately $590 million to Moderna to accelerate the development of mRNA-based pandemic influenza vaccines and enhance mRNA platform capabilities so the U.S. is better prepared to respond to other emerging infectious diseases, according to a release from HHS.